Target disease:
Effect type:
Expressivity
Modifier effect:
Altered severity
Evidence:
OR=1.33, 95% CI:1.05-1.69; p=0.017
Effect:
We identified the IL17RA rs4819554 SNP as a risk factor for PsO. The IL17E rs79877597 SNP was a modifier of the risk for PsO disease severity and PsA.